Capstone Investment Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.57M | Buy |
32,400
+18,500
| +133% | +$5.5M | 0.02% | 297 |
|
|
2025
Q4 | $3.8M | Sell |
13,900
-6,700
| -33% | -$1.82M | 0.01% | 427 |
|
|
2025
Q3 | $5.57M | Buy |
20,600
+7,600
| +58% | +$2.07M | 0.01% | 447 |
|
|
2025
Q2 | $3.58M | Sell |
13,000
-20,900
| -62% | -$5.68M | 0.01% | 470 |
|
|
2025
Q1 | $8.99M | Sell |
33,900
-39,000
| -53% | -$9.62M | 0.02% | 325 |
|
|
2024
Q4 | $16.9M | Buy |
72,900
+20,800
| +40% | +$4.78M | 0.04% | 246 |
|
|
2024
Q3 | $11.5M | Buy |
52,100
+11,300
| +28% | +$2.34M | 0.04% | 275 |
|
|
2024
Q2 | $8.02M | Buy |
40,800
+7,700
| +23% | +$1.59M | 0.03% | 344 |
|
|
2024
Q1 | $7.13M | Sell |
33,100
-24,000
| -42% | -$5.04M | 0.03% | 341 |
|
|
2023
Q4 | $12M | Buy |
57,100
+39,000
| +215% | +$8.32M | 0.04% | 307 |
|
|
2023
Q3 | $3.62M | Buy |
18,100
+2,600
| +17% | +$517K | 0.02% | 523 |
|
|
2023
Q2 | $2.87M | Buy |
15,500
+1,900
| +14% | +$351K | 0.01% | 536 |
|
|
2023
Q1 | $2.6M | Sell |
13,600
-6,400
| -32% | -$1.16M | 0.01% | 524 |
|
|
2022
Q4 | $3.36M | Sell |
20,000
-26,500
| -57% | -$4.61M | 0.02% | 521 |
|
|
2022
Q3 | $8.24M | Sell |
46,500
-6,500
| -12% | -$1.28M | 0.05% | 271 |
|
|
2022
Q2 | $10.8M | Sell |
53,000
-219,400
| -81% | -$46.5M | 0.05% | 248 |
|
|
2022
Q1 | $64.8M | Sell |
272,400
-169,700
| -38% | -$39.9M | 0.18% | 71 |
|
|
2021
Q4 | $101M | Buy |
442,100
+60,000
| +16% | +$13.2M | 0.17% | 107 |
|
|
2021
Q3 | $73.9M | Buy |
382,100
+53,100
| +16% | +$10.8M | 0.15% | 125 |
|
|
2021
Q2 | $70M | Buy |
329,000
+46,100
| +16% | +$9.73M | 0.16% | 124 |
|
|
2021
Q1 | $57.8M | Buy |
282,900
+95,300
| +51% | +$18.8M | 0.17% | 117 |
|
|
2020
Q4 | $34.2M | Sell |
187,600
-24,400
| -12% | -$4.15M | 0.11% | 142 |
|
|
2020
Q3 | $35.5M | Buy |
212,000
+60,900
| +40% | +$10.3M | 0.18% | 101 |
|
|
2020
Q2 | $24.6M | Buy |
151,100
+37,900
| +33% | +$6.79M | 0.16% | 115 |
|
|
2020
Q1 | $19.6M | Sell |
113,200
-32,600
| -22% | -$6.49M | 0.31% | 53 |
|
|
2019
Q4 | $29.3M | Buy |
145,800
+28,800
| +25% | +$5.91M | 0.16% | 142 |
|
|
2019
Q3 | $24.7M | Buy |
117,000
+11,900
| +11% | +$2.49M | 0.17% | 123 |
|
|
2019
Q2 | $20.4M | Buy |
105,100
+50,700
| +93% | +$9.35M | 0.15% | 153 |
|
|
2019
Q1 | $8.95M | Buy |
54,400
+17,900
| +49% | +$3.16M | 0.08% | 235 |
|
|
2018
Q4 | $6.87M | Sell |
36,500
-2,500
| -6% | -$462K | 0.08% | 192 |
|
|
2018
Q3 | $6.64M | Buy |
39,000
+26,900
| +222% | +$4.53M | 0.08% | 204 |
|
|
2018
Q2 | $1.98M | Buy |
+12,100
| New | +$1.98M | 0.03% | 284 |
|
Other funds holding CME
VCM
VPM
Capstone Investment Advisors's CME Position: Q1 2026 in Review
Capstone Investment Advisors increased its CME Group (CME) stake by 1% in Q1 2026, buying an estimated $184K and bringing the position to 60,620 shares worth $17.9M. The position accounts for 0.03% of the portfolio, ranked #192.
Capstone Investment Advisors first reported a position in CME in Q1 2016 and has held it in 25 quarters since. 1,792 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Capstone Investment Advisors held 60,620 shares of CME Group worth $17.9M as of Q1 2026.
- Capstone Investment Advisors bought 620 CME Group shares in Q1 2026, an estimated $184K.
- CME Group made up 0.03% of Capstone Investment Advisors's portfolio in Q1 2026, its #192 holding.
- Capstone Investment Advisors first reported a position in CME Group in Q1 2016 and has held it in 25 quarters since.
- 1,792 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.